Invention Grant
- Patent Title: Inhibitors for treatment of hematological malignancies
-
Application No.: US16920831Application Date: 2020-07-06
-
Publication No.: US11648255B2Publication Date: 2023-05-16
- Inventor: Marek Mraz , Vaclav Seda , Laura Ondrisova
- Applicant: Masarykova Univerzita , Fakultni Nemocnice Brno
- Applicant Address: CZ Brno
- Assignee: MASARYKOVA UNIVERZITA,FAKULTNI NEMOCNICE BRNO
- Current Assignee: MASARYKOVA UNIVERZITA,FAKULTNI NEMOCNICE BRNO
- Current Assignee Address: CZ Brno; CZ Brno
- Agency: Notaro, Michalos & Zaccaria P.C.
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K31/381 ; A61K31/4164 ; A61K31/496 ; A61K31/4196 ; A61K31/519 ; A61K31/4245 ; A61K31/196 ; A61K31/433 ; A61K31/4436 ; A61K45/06 ; A61P35/00 ; A61P35/02
Abstract:
A new approach to treatment of hematological malignancies. A GAB1 inhibitor for use in a method of treatment of a hematological malignancy is disclosed. The GAB1 inhibitor may be administered alone, or simultaneously or sequentially with a BTK inhibitor to achieve a synergistic effect.
Public/Granted literature
- US20220000879A1 Inhibitors for Treatment of Hematological Malignancies Public/Granted day:2022-01-06
Information query
IPC分类:
